Antiviral Drug Development: Overcoming Challenges to the Current Model
PharmaTalkRadio11 Okt 2024

Antiviral Drug Development: Overcoming Challenges to the Current Model

As viruses evolve to resist vaccines and therapeutics, new targeted approaches to deliver broad-spectrum antivirals are needed. In this podcast, Anil Diwan, President and Executive Chairman of NanoViricides Incorporated, explains some of the shortcomings of the current model of antiviral drug development and how NanoViricides developed a nanotechnology with a different approach to develop and deliver antiviral drugs. Anil also presents an overview of the scientific and clinical development of NanoViricides lead program, NV-387 as well as potential applications in different indications. For more information about NanoViricides Incorporated, visit NanoViricides.com. For more information about the annual PODD drug delivery conference, please visit Drug-Delivery.org.

Det här avsnittet är hämtat från ett öppet RSS-flöde och publiceras inte av Podme. Det kan innehålla reklam.

Avsnitt(461)

Populärt inom Vetenskap

dumma-manniskor
allt-du-velat-veta
p3-dystopia
rss-vetenskapsradion
rss-ufobortom-rimligt-tvivel
medicinvetarna
bildningspodden
paranormalt-med-caroline-giertz
kapitalet-en-podd-om-ekonomi
det-morka-psyket
rss-vetenskapsradion-2
sexet
svd-nyhetsartiklar
vetenskapsradion
pojkmottagningen
ufo-sverige
rss-ronden
rss-personlighetspodden
halsorevolutionen
hacka-livet